Exhibit 10.17 FINANCIAL CONSULTING AGREEMENT THIS AGREEMENT is made and entered into as of May 10, 2003, by and between CYTRX CORPORATION, located at 11726 San Vicente Blvd., Suite 650, Los Angeles, CA 90049 ("CytRx") and JAMES SKALKO, located 1858...Financial Consulting Agreement • August 14th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2003 Company Industry
Exhibit 10.10 INVESTMENT BANKING AGREEMENT This Agreement is made as of this day April 1, 2003, by and between CytRx Corporation; having its business office at 11726 San Vicente Boulevard, Suite 650 , Los Angeles, California 90049 (the "Company") and...Investment Banking Agreement • August 14th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 14th, 2003 Company Industry Jurisdiction
Exhibit 10.16 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Second Amended and Restated Employment Agreement (this "Agreement") is made and entered into as of this 10th day of June, 2003, by and between CytRx Corporation, a Delaware...Employment Agreement • August 14th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 14th, 2003 Company Industry Jurisdiction
April 3, 2003 Steve Kriegsman President and Chairman CytRx Corporation 11726 San Vincente Blvd. Los Angeles, CA 90049 Phone: (310) 826-5658 RE: INVESTMENT BANKING AGREEMENT WITH J. P. TURNER & Company, LLC Dear Mr. Kriegsman, This letter (the...Investment Banking Agreement • August 14th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2003 Company Industry
Exhibit 10.14 June 6, 2003 Mr. Steven Kriegsman CytRx Corporation 11726 San Vicente Blvd. Suite 650 Los Angeles, CA 90049 Dear Steve: This letter will memorialize our agreement to modify the Engagement Agreement between CytRx Corporation and Cappello...Engagement Agreement • August 14th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2003 Company IndustryThis letter will memorialize our agreement to modify the Engagement Agreement between CytRx Corporation and Cappello Capital Corp. dated May 16, 2003. The Fees and Expenses section of the Engagement Agreement, subsection (a), is hereby amended to delete the provision that provides for the crediting of any retainer amounts against any fees to be paid to Cappello Capital Corp. under the Agreement.
FIRST AMENDMENTInvestment Banking Agreement • August 14th, 2003 • Cytrx Corp • Biological products, (no disgnostic substances)
Contract Type FiledAugust 14th, 2003 Company Industry